Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells

Translational Research

Volumn 166, Issue 2, 2015, Pages 111-133

  Marginean, Alexandru ^a   Sharma Walia, Neelam ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; FOCAL ADHESION KINASE; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; VASCULOTROPIN RECEPTOR; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; AUTACOID; LIPOXIN A; LIPOXIN RECEPTOR; PTGS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SARCOMA CELL; ANGIOGENESIS; BIOLOGICAL MODEL; DOWN REGULATION; DRUG EFFECTS; ENDOTHELIUM CELL; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHOSPHORYLATION; SARCOMA, KAPOSI; SECRETION (PROCESS); TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 5-LIPOXYGENASE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPOXINS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RECEPTORS, LIPOXIN; SARCOMA, KAPOSI; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84937635434     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.02.009     Document Type: Article

References (92)

1. U.N. Das Lipoxins as biomarkers of lupus and other inflammatory conditions Lipids Health Dis 10 2011 76
2. N.B. Janakiram, A. Mohammed, and C.V. Rao Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer Cancer Metastasis Rev 30 2011 507 523
3. N.B. Janakiram, and C.V. Rao Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer Curr Mol Med 9 2009 565 579
4. M. Chen, M. Divangahi, H. Gan, and et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death J Exp Med 205 2008 2791 2801
5. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Annu Rev Pathol 3 2008 279 312
6. M.W. Kieran, R. Kalluri, and Y.J. Cho The VEGF pathway in cancer and disease: responses, resistance, and the path forward Cold Spring Harb Perspect Med 2 2012 a006593
7. L. Claesson-Welsh Receptor talk and tumor cell walk in glioblastoma Cancer Cell 22 2012 1 2
8. Y. Chang, E. Cesarman, M.S. Pessin, and et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
9. V. Fiorelli, R. Gendelman, M.C. Sirianni, and et al. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 91 1998 956 967
10. F. Samaniego, P.D. Markham, R. Gendelman, and et al. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development Am J Pathol 152 1998 1433 1443
11. O. Radu, and L. Pantanowitz Kaposi sarcoma Arch Pathol Lab Med 137 2013 289 294
12. L. Cancian, A. Hansen, and C. Boshoff Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming Trends Cell Biol 23 2013 421 432
13. A. Albini, G. Fontanini, L. Masiello, and et al. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2 AIDS 8 1994 1237 1244
14. A. Albini, G. Pennesi, F. Donatelli, R. Cammarota, S. De Flora, and D.M. Noonan Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention J Natl Cancer Inst 102 2010 14 25
15. A. Albini, M. Morini, F. D'Agostini, and et al. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine Cancer Res 61 2001 8171 8178
16. A. Albini, F. D'Agostini, D. Giunciuglio, I. Paglieri, R. Balansky, and S. De Flora Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine Int J Cancer 61 1995 121 129
17. M. Morini, T. Cai, M.G. Aluigi, and et al. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis Int J Biol Markers 14 1999 268 271
18. C. Boshoff Kaposi's sarcoma biology IUBMB Life 53 2002 259 261
19. N. Dupin, C. Fisher, P. Kellam, and et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma Proc Natl Acad Sci U S A 96 1999 4546 4551
20. T.V. Sharp, H.W. Wang, A. Koumi, and et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function J Virol 76 2002 802 816
21. H.W. Wang, T.V. Sharp, A. Koumi, G. Koentges, and C. Boshoff Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin EMBO J 21 2002 2602 2615
22. Y. Jin, M. Arita, Q. Zhang, and et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators Invest Ophthalmol Vis Sci 50 2009 4743 4752
23. M. Romano Lipoxin and aspirin-triggered lipoxins ScientificWorldJournal 10 2010 1048 1064
24. P.F. Cezar-de-Mello, V. Nascimento-Silva, C.G. Villela, and I.M. Fierro Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly Oncogene 25 2006 122 129
25. X.H. Liu, A. Kirschenbaum, M. Lu, and et al. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line J Biol Chem 277 2002 50081 50086
26. J.Y. Liu, J. Yang, B. Inceoglu, and et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Biochem Pharmacol 79 2010 880 887
27. W. Khovidhunkit, M.S. Kim, R.A. Memon, and et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host J Lipid Res 45 2004 1169 1196
28. T. Takano, S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J Exp Med 185 1997 1693 1704
29. J.R. Brown, and R.N. DuBois Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture Chest 125 5 suppl 2004 134S 140S
30. A. George Paul, N. Sharma-Walia, N. Kerur, C. White, and B. Chandran Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen Cancer Res 70 2010 3697 3708
31. N. Sharma-Walia, K. Patel, K. Chandran, and et al. COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP Oncogenesis 1 2012 e5
32. A.G. Paul, N. Sharma-Walia, and B. Chandran Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma PLoS One 6 2011 e24379
33. N. Sharma-Walia, A.G. Paul, V. Bottero, and et al. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion PLoS Pathog 6 2010 e1000777
34. N. Sharma-Walia, H. Raghu, S. Sadagopan, and et al. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression J Virol 80 2006 6534 6552
35. N. Sharma-Walia, K. Chandran, K. Patel, M.V. Veettil, and A. Marginean The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis J Virol 88 2014 2131 2156
36. H.H. Krishnan, N. Sharma-Walia, D.N. Streblow, P.P. Naranatt, and B. Chandran Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells J Virol 80 2006 1167 1180
37. H. Raghu, N. Sharma-Walia, M.V. Veettil, S. Sadagopan, and B. Chandran Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells J Virol 83 2009 4895 4911
38. G.S. Jack, A.R. Brash, S.J. Olson, and et al. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia Hum Pathol 31 2000 1146 1154
39. S.J. Muga, P. Thuillier, A. Pavone, and et al. 8S-Lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes Cell Growth Differ 11 2000 447 454
40. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular, and molecular biology Annu Rev Biochem 69 2000 145 182
41. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97 120
42. R.N. Dubois Review article: cyclooxygenase - a target for colon cancer prevention Aliment Pharmacol Ther 14 suppl 1 2000 64 67
43. J. Claria Regulation of cell proliferation and apoptosis by bioactive lipid mediators Recent Pat Anticancer Drug Discov 1 2006 369 382
44. G. Neufeld, T. Cohen, H. Gitay-Goren, and et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants Cancer Metastasis Rev 15 1996 153 158
45. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
46. Z. Poltorak, T. Cohen, R. Sivan, and et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix J Biol Chem 272 1997 7151 7158
47. Z. Poltorak, T. Cohen, and G. Neufeld The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases Herz 25 2000 126 129
48. L. Labrecque, I. Royal, D.S. Surprenant, C. Patterson, D. Gingras, and R. Beliveau Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol Mol Biol Cell 14 2003 334 347
49. S. Muralidhar, G. Veytsmann, B. Chandran, D. Ablashi, J. Doniger, and L.J. Rosenthal Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12) J Clin Virol 16 2000 203 213
50. C. Boshoff, and R.A. Weiss Kaposi's sarcoma-associated herpesvirus Adv Cancer Res 75 1998 57 86
51. G. Gaidano, K. Cechova, Y. Chang, P.S. Moore, D.M. Knowles, and R. Dalla-Favera Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions Leukemia 10 1996 1237 1240
52. D. Dittmer, C. Stoddart, R. Renne, and et al. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice J Exp Med 190 1999 1857 1868
53. M. Sturzl, C. Blasig, A. Schreier, and et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma Int J Cancer 72 1997 68 71
54. N. Vannini, G. Lorusso, R. Cammarota, and et al. The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent Mol Cancer Ther 6 12 Pt 1 2007 3139 3146
55. F. Tosetti, N. Ferrari, S. De Flora, and A. Albini Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents FASEB J 16 2002 2 14
56. M.G. Aluigi, S. De Flora, F. D'Agostini, A. Albini, and G. Fassina Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin Anticancer Res 20 2000 3183 3187
57. F. D'Agostini, M. Bagnasco, D. Giunciuglio, A. Albini, and S. De Flora Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice Int J Oncol 13 1998 217 224
58. T. Cai, G. Fassina, M. Morini, and et al. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis Lab Invest 79 1999 1151 1159
59. S. De Flora, F. D'Agostini, L. Masiello, D. Giunciuglio, and A. Albini Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models Int J Cancer 67 1996 842 848
60. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
61. S. Koch, and L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Cold Spring Harb Perspect Med 2 2012 a006502
62. R.N. Dubois, S.B. Abramson, L. Crofford, and et al. Cyclooxygenase in biology and disease FASEB J 12 1998 1063 1073
63. C.S. Williams, M. Mann, and R.N. DuBois The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 1999 7908 7916
64. A.J. Dannenberg, and K. Subbaramaiah Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 4 2003 431 436
65. A.M. Tager, and A.D. Luster BLT1 and BLT2: the leukotriene B(4) receptors Prostaglandins Leukot Essent Fatty Acids 69 2003 123 134
66. H.E. Claesson On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma Prostaglandins Other Lipid Mediat 89 2009 120 125
67. H.E. Claesson, W.J. Griffiths, A. Brunnstrom, and et al. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma FEBS J 275 2008 4222 4234
68. H.E. Claesson, B. Odlander, and P.J. Jakobsson Leukotriene B4 in the immune system Int J Immunopharmacol 14 1992 441 449
69. N. Sharma-Walia, A.G. Paul, K. Patel, K. Chandran, W. Ahmad, and B. Chandran Nfat and Creb regulate Kaposi's sarcoma associated herpes virus (KSHV) induced cyclooxygenase-2 (COX-2) J Virol 84 2010 12733 12753
70. S.H. Sin, and D.P. Dittmer Cytokine homologs of human gammaherpesviruses J Interferon Cytokine Res 32 2012 53 59
71. C.B. Foster, T. Lehrnbecher, S. Samuels, and et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus Blood 96 2000 2562 2567
72. Z. Qin, P. Kearney, K. Plaisance, and C.H. Parsons Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes J Leukoc Biol 87 2010 25 34
73. S.A. Miles, A.R. Rezai, J.F. Salazar-Gonzalez, and et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6 Proc Natl Acad Sci U S A 87 1990 4068 4072
74. A. Li, S. Dubey, M.L. Varney, B.J. Dave, and R.K. Singh IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis J Immunol 170 2003 3369 3376
75. N. Sharma-Walia, H.H. Krishnan, P.P. Naranatt, L. Zeng, M.S. Smith, and B. Chandran ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection J Virol 79 2005 10308 10329
76. K. Murakami-Mori, S. Mori, B. Bonavida, and S. Nakamura Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells J Immunol 162 1999 3672 3679
77. B. Chandran Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells J Virol 84 2010 2188 2199
78. J. Chang, R. Renne, D. Dittmer, and D. Ganem Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication Virology 266 2000 17 25
79. S. Sadagopan, N. Sharma-Walia, M.V. Veettil, and et al. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression J Virol 81 2007 3949 3968
80. A. Badescu, A. Couvelard, and A. Handra-Luca Akt pathway protein expression in gastrointestinal Kaposi sarcomas: relevance for tumor biology APMIS 122 2014 518 525
81. A. Sodhi, S. Montaner, V. Patel, and et al. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor Proc Natl Acad Sci U S A 101 2004 4821 4826
82. A.P. Bhatt, and B. Damania AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV Front Immunol 3 2012 401
83. O.F. Dyson, C.M. Traylen, and S.M. Akula Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1 J Biol Chem 285 2010 37491 37502
84. S.E. Wang, F.Y. Wu, H. Chen, M. Shamay, Q. Zheng, and G.S. Hayward Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway J Virol 78 2004 4248 4267
85. N. Cheng, D.M. Brantley, and J. Chen The ephrins and Eph receptors in angiogenesis Cytokine Growth Factor Rev 13 2002 75 85
86. M. He, W. Zhang, T. Bakken, and et al. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2 Cancer Res 72 2012 3582 3592
87. P.M. Ojala, and T.F. Schulz Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation Semin Cancer Biol 26 2014 69 77
88. R. Masood, G. Xia, D.L. Smith, and et al. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium Blood 105 2005 1310 1318
89. L. Wang, N. Wakisaka, C.C. Tomlinson, and et al. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors Cancer Res 64 2004 2774 2781
90. P.W. Ford, K.E. Hamden, A.G. Whitman, J.A. McCubrey, and S.M. Akula Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infection Cancer Biol Ther 3 2004 876 881
91. R. Sivakumar, N. Sharma-Walia, H. Raghu, and et al. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications J Virol 82 2008 1759 1776
92. M. Groger, R. Loewe, W. Holnthoner, and et al. IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells J Immunol 173 2004 7161 7169